AADI

Aadi Bioscience (AADI)

About Aadi Bioscience (AADI)

Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Los Angeles, CA.

Details

Daily high

$1.96

Daily low

$1.90

Price at open

$1.94

52 Week High

$5.70

52 Week Low

$1.21

Market cap

47.8M

Dividend yield

0.00%

Volume

74,899

Avg. volume

153,292

P/E ratio

-.80

Aadi Bioscience News